Back to mobile site

More on ADLR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ADLR Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 13.16M
Short-term investments 10M
Accounts receivable 3.06M
Inventory 1.13M
Prepaid expenses and other current assets 942.77K
Total current assets 28.29M
Equipment and leasehold improvements, net 330.42K
Other assets 107K
Intangible asset (Note 3) 19.19M
Total assets 47.92M
Accounts payable 1.02M
Accrued expenses 8.58M
Payable to Glaxo-current (Note 3) 2.8M
Deferred revenue and rent-current 171.73K
Total current liabilities 12.56M
Deferred revenue and rent-non-current 114.49K
Payable to Glaxo-non-current (Note 3) 14.18M
Total liabilities 26.85M
Commitments 0
Stockholders' equity:
Preferred stock, $0.01 par value 0
Common stock, $0.0001 par value; 99,000,000 shares authorized; 46,488,675 and 46,433,663 shares issued; 46,464,484 and 46,414,759 shares outstanding at June 30, 2011 and December 31, 2010, respectively 4.66K
Additional paid-in capital 551.51M
Treasury stock, at cost, 24,191 and 18,904 shares at June 30, 2011 and December 31, 2010, respectively -36.61K
Unrealized gains on available for sale securities 1.12K
Accumulated deficit -530.42M
Total stockholders' equity 21.06M
Total liabilities and stockholders' equity 47.92M
Stockholders' equity:
Preferred stock, $0.01 par value 0